EMD 21388

Known as: EMD-21388 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2013
01219882013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The synthetic flavonoids EMD 23188 and EMD 49209, developed as T4 analogs, displace T4 from transthyretin, and in vitro they… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
1996
1996
1996
In nonthyroidal illness, numerous drugs such as glucocorticoids, dopamine, fenclofenac, furosemide and diphenylhydantoin may… (More)
Is this relevant?
1993
1993
A cell culture model for the blood-cerebrospinal fluid barrier in choroid plexus was developed. The relationship between… (More)
Is this relevant?
1993
1993
Apolipoprotein-E (apoE) has been shown by noncovalent binding and photoaffinity labeling with [125I]T4 to possess a single L-T4… (More)
Is this relevant?
1992
1992
To test whether plasma transthyretin (TTR) might play a specific direct role in the transfer of T4 from the plasma to tissues, in… (More)
Is this relevant?
1991
1991
In vitro, the synthetic flavonoid EMD 21388 appears to be a potent inhibitor of thyroxine (T4) 5'-deiodinase and diminishes… (More)
Is this relevant?
1990
1990
Naturally occurring and synthetic plant flavonoids, such as EMD 21388, are potent inhibitors of thyroid hormone 5'-deiodinase (5… (More)
Is this relevant?
1989
1989
Naturally occurring and synthetic flavonoids are potent inhibitors of thyroid hormone 5'-deiodination and binding to human serum… (More)
Is this relevant?
1988
1988
Flavonoids are potent non-toxic ITH deiodinase inhibitors in microsomal membranes, and intact rat hepatocytes. Flavonoids are… (More)
Is this relevant?